innoveas International Ltd. is a unique international company transforming world class technologies and innovative scientific ideas into game-changing companies. It has been established through the merger of the businesses controlled by innoveas AG and Sultan Scientific Ltd..
innoveas International offers an unrivalled resource for the commercialisation of innovative, early-stage science and technology and is a long-established partner with the experience to deliver both financial and non-financial impacts on a substantial scale. innoveas is present where it matters most: with Germany boasting the largest publicly funded R&D programmes in Europe, London being the largest European capital market and the USA being the world’s most significant capital, healthcare and technology market. innoveas International provides its companies the best support possible by:
With decades of local market knowledge and relationships in Europe and the USA, the management team has consistently demonstrated its ability to convert early-stage science and technology opportunities into substantial companies generating billion dollar returns.
The innoveas International team is based in Germany, Sweden, Italy, France, the UK and USA and works closely with institutions in the public research sector to screen, protect and develop their intellectual property and to help access additional non-dilutive grant funding during their early stage development. innoveas International can offer both unique and privileged access to some of Europe’s leading universities and institutes providing a constant stream of new and innovative technology opportunities.
Three of the US leading technology investors are members of the innoveas International Management or Advisory Board. Through their relationships with the investment community, innoveas International has the capability of helping portfolio companies grow and optimise investment and exit solutions.